One-year outcomes of half-fluence photodynamic therapy combined with intravitreal injection of aflibercept for pachychoroid neovasculopathy without polypoidal lesions-Reference-Cited by-同舟云学术

One-year outcomes of half-fluence photodynamic therapy combined with intravitreal injection of aflibercept for pachychoroid neovasculopathy without polypoidal lesions

Published:2020-02-03 Issue:2 Volume:64 Page:203-209
ISSN:0021-5155
Container-title:Japanese Journal of Ophthalmology
language:en
Short-container-title:Jpn J Ophthalmol

Author:

Matsumoto Hidetaka,Mukai Ryo,Kikuchi Yuka,Morimoto Masahiro,Akiyama Hideo

Publisher

Springer Science and Business Media LLC

Subject

Ophthalmology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s10384-020-00722-7.pdf

Reference32 articles.

1. Gallego-Pinazo R, Dolz-Marco R, Gómez-Ulla F, Mrejen S, Freund KB. Pachychoroid diseases of the macula. Med Hypothesis Discov Innov Ophthalmol. 2014;3:111–5.

2. Fung AT, Yannuzzi LA, Freund KB. Type 1 (sub-retinal pigment epithelial) neovascularization in central serous chorioretinopathy masquerading as neovascular age-related macular degeneration. Retina. 2012;32:1829–37. https://doi.org/10.1097/IAE.0b013e3182680a66.

3. Yannuzzi LA, Freund KB, Goldbaum M, Scassellati-Sforzolini B, Guyer DR, Spaide RF, et al. Polypoidal choroidal vasculopathy masquerading as central serous chorioretinopathy. Ophthalmology. 2000;107:767–77.

4. Pang CE, Freund KB. Pachychoroid neovasculopathy. Retina. 2015;35:1–9. https://doi.org/10.1097/IAE.0000000000000331.

5. Matsumoto H, Hiroe T, Morimoto M, Mimura K, Ito A, Akiyama H. Efficacy of treat-and-extend regimen with aflibercept for pachychoroid neovasculopathy and Type 1 neovascular age-related macular degeneration. Jpn J Ophthalmol. 2018;62:144–50. https://doi.org/10.1007/s10384-018-0562-0.

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pachychoroid Spectrum Disease: Comparison of Patients with Central Serous Chorioretinopathy Complicated with Pachychoroid Neovasculopathy;Korean Journal of Ophthalmology;2024-08-05

2. Three-year outcome of photodynamic therapy combined with VEGF inhibitor for pachychoroid neovasculopathy;Graefe's Archive for Clinical and Experimental Ophthalmology;2024-05-09

3. Intravitreal anti-vascular endothelial growth factor and combined photodynamic therapy for pachychoroid neovasculopathy: long-term treatment outcomes;Graefe's Archive for Clinical and Experimental Ophthalmology;2024-01-31

4. Pachychoroid Spectrum Disorders: An Updated Review;Journal of Ophthalmic and Vision Research;2023-04-19

5. Two-Year Results of a Treat and Extend Regimen with Aflibercept in Caucasian Patients with Pachychoroid Neovasculopathy;Seminars in Ophthalmology;2023-03-28